BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 06, 2009
 |  BC Week In Review  |  Company News  |  Deals

Plethora, Shionogi deal

Shionogi's Sciele Pharma Inc. subsidiary will takeover U.S. development of Plethora's PSD502 for premature ejaculation in exchange for $13.7 million in cash. Plethora will receive $7 million in cash and the biotech's debt providers Paul Capital Partners and ETV...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >